> Start-ups > Biopôle Start-up Fund

BIOPÔLE START-UP FUND:
FLAGSHIP SUPPORT FOR OUTSTANDING ENTREPRENEURS

Are you a passionate Biopôle-based entrepreneur? And are you in need of a financial boost to kick-start your innovation? Enter the Biopôle Start-up Fund: a flagship initiative that helps the most promising life sciences ventures on campus to focus on what they do best. With up to three years of support with the costs of rental, research and development and key services, Biopôle SA supports entrepreneurial passion and early-stage innovation. Even better, it’s no strings attached: no equity demands, no loan repayments, just more time and resources to make an impact on human health through innovation.

 

Application form

NO STRINGS ATTACHED

90,000
CHF of total annual support
40'000 CHF for digital health companies
40,000
CHF/year for rental
of infrastructure at Biopôle
20,000
CHF/year for R&D services
or consultancy, salaries and training
30,000
CHF/year for R&D materials
10,000 CHF for digital health companies

WHAT YOU GET: UP TO THREE YEARS OF FINANCIAL SUPPORT

We’ll give up to CHF 40,000 per year for up to three years to start-ups working in digital health and up to CHF 90,000 per year for up to three years to those in any other area of the life sciences.

More specifically, successful, non digital health applicants will enjoy:

  • up to CHF 40,000 per year to spend on infrastructure rental
  • up to CHF 20,000 per year to spend on research or administrative services, consultancy, staff salaries or training for key personnel
  • up to CHF 30,000 to spend on laboratory equipment for research and development

For digital health companies, we’ll provide:

  • up to CHF 10,000 per year to spend on infrastructure rental
  • up to CHF 20,000 per year to spend on research or administrative services, consultancy, staff salaries or training for key personnel
  • Up to CHF 10,000 to spend on equipment for research and development

 

 

YOUR COMMITTMENT: GIVING BACK TO THE COMMUNITY

Biopôle SA demands no equity or debt-like reimbursement in return for the funding provided; the support is given with no strings attached. However, the most successful beneficiaries of the fund – those having raised a further CHF 10 million in financing after being accepted– will be expected to pay back what they received in a spirit of solidarity, thus ensuring that future generations of start-ups can benefit from the same support. The only other expectations are that beneficiaries will stay at Biopôle for three years following their funding award, and that they’ll communicate about the support received through all appropriate channels to help raise the Fund’s profile.

WHO REVIEWS APPLICATIONS: THE SCIENTIFIC ADVISORY BOARD

The primary goal of the Scientific Advisory Board (SAB) is to recommend the best and brightest start-ups from the applications received. It then works with the Biopôle management team to help successful applicants put down solid roots in the dynamic entrepreneurial ecosystem of the canton of Vaud. The SAB supports them throughout their journey at Biopôle, ensuring they get the help they need when they need it.

The SAB is made up of professionals with complementary expertise and perspectives, including representatives of academia, investment, business, technology transfer and entrepreneurship.

Tanja Dowe
CEO, Debiopharm Innovation Fund
Mickael Friedrich
CEO, Distalmotion
Ronald Kempers
CEO and CFO, Mymetics Corporation
Stefan Kohler
Director Technology Transfer Office, UNIL & CHUV
Vincent Ossipow
Partner, Omega Funds
Andy Oates
Dean, EPFL's School of Life Sciences
Nicolas Mermod
Professor Emeritus, UNIL
Philippe Renaud
Full Professor, Microsystems Laboratory, EPFL
Pierre-Jean Wipff
Innovation Advisor, Innovaud
Nasri Nahas
CEO, Biopôle SA

HOW AND WHEN TO APPLY: THE SELECTION PROCESS

Start-ups can apply to the fund at any time. The SAB assesses the applications received at the end of each calendar quarter and presents recommendations to the Board of Directors of Biopôle SA, which then has the final say on which companies will be supported by the fund. Funding decisions are based on the scientific quality of the project, the relevance of the company’s business plan and the credentials of the management team.

Next application deadline: 30 September 2021

WHO CAN APPLY: BIOPÔLE LIFE SCIENCES START-UPS

Any start-up based at Biopôle is eligible to apply to the fund, regardless of the life sciences domain it is operating in. However, the start-up must:

  • be hosted at Biopôle on a lease of no less than 12 months
  • have been registered for less than 5 years
  • be working in the life sciences (companies providing services only are not eligible to apply)
  • have raised less than CHF 5 million in funding since it was founded